Skip to content

National Survey of Symptoms of People Aged 70 and Overs Diagnosed With COVID-19

National Survey of Symptoms of People Aged 70 and Overs Diagnosed With COVID-19

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04343781
Acronym
COVID19PUGG2
Enrollment
353
Registered
2020-04-13
Start date
2020-03-22
Completion date
2020-04-05
Last updated
2020-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19, SARS-CoV-2

Brief summary

Cross-sectional study based on a French national survey aimed to described and identify the most frequent symptoms of COVID-19 older patients.

Detailed description

This cross-sectional survey was initiated and conducted by the French Society of Geriatrics and Gerontology. A standardized questionnaire was emailed to 1600 geriatrician members of the French Society of Geriatrics and Gerontology throughout France between March 22, 2020 and April 5, 2020. Geriatricians were asked to complete the survey for their last 10 patients infected by the SARS-CoV-2. The study was declared to the Commission Nationale de l'Informatique et des Libertés (CNIL) under the number ar20-0031v1. For each patient, demographic characteristics (age, gender, residence place, care place, autonomy according to the Groupe Iso Ressource (GIR)), medical history (presence of major neurocognitive disorder, hypertension, diabetes, asthma or chronic obstructive pulmonary disease (COPD), heart pathology, severe renal failure with a clearance of creatinine under 30ml/min, solid or liquid cancer) were collected. The symptoms within de 72 hours of the actual disease were also collected for each patient including geriatric syndromes (fall, hypoactive or hyperactive delirium, altered general status, altered conscience), general symptoms (temperature, blood pressure), respiratory symptoms (cough, polypnea), ear nose and throat (ENT) symptoms (rhinorrhea, odynophagia, otalgia, conjunctivitis, ageusia or dysgeusia, anosmia), digestive symptoms (diarrhea, nausea or vomiting), and blood formula modification (leucopenia (with count if available), lymphopenia (with count if available), thrombopenia (with count if available). Procedure Data were collected by the physician who was in charge of the patient between March 22, 2020 and April 5, 2020. Given the main objective of the study was only descriptive, no calculation was required concerning the number of subjects to include in the study.

Interventions

OTHERobservation

observation of clinical symptoms related to COVID-19 disease

Sponsors

University Hospital, Angers
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
70 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* confirmed COVID-19 defined by a positive RT-PCR to SARS-CoV-2

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frameDescription
symptoms of COVID-19 in older patientsat baselinedescription and identification of symptoms presented by older patients with confirmed COVID-19

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026